Trial Profile
Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Alcohol withdrawal
- Focus Therapeutic Use
- 12 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 06 Oct 2008 New trial record.